PASITHEA THERAPEUTICS CORP. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price
PASITHEA THERAPEUTICS CORP. (KTTA) had Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price of $0.72 per share as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice · last filed 2026-03-30
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $0.72.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $8.13.
- 2025-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $8.13.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $8.13.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price |
|---|---|
| 2025-12-31 | $0.72 10-K · filed 2026-03-30 |
| 2025-06-30 | $8.13 10-Q · filed 2025-08-14 |
| 2025-03-31 | $8.13 10-Q · filed 2025-05-15 |
| 2024-12-31 | $8.13 10-K · filed 2026-03-30 |
| 2024-09-30 | $8.13 10-Q · filed 2025-11-13 |
| 2024-06-30 | $8.13 10-Q · filed 2024-08-13 |
| 2024-03-31 | $8.13 10-Q · filed 2024-05-14 |
| 2023-12-31 | $0.49 10-K · filed 2025-03-24 |
| 2022-12-31 | $1.10 10-K · filed 2024-03-29 |
| 2021-12-31 | $3.47 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |